On the other hand, the hepatic expression of hepcidin and the expression of its important up-stream regulators could be related to lipid metabolism pathways in liver or at least sharing a common pathogenic mechanism, which might have implications for NAFLD pathogenesis. The gene discussed is HAMP; the disease is metabolic dysfunction-associated steatotic liver disease.